Healthcare provider profile · identity verified

Andrew M. Mohler, MD

Family Practice · GRAND JUNCTION, CO · NPI 1790768430

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	535	117
Atorvastatin Calcium	Atorvastatin Calcium	404	100
Losartan Potassium	Losartan Potassium	380	102
Amlodipine Besylate	Amlodipine Besylate	328	85
Lisinopril	Lisinopril	318	85
Trazodone Hcl	Trazodone Hcl	303	68
Omeprazole	Omeprazole	186	52
Pantoprazole Sodium	Pantoprazole Sodium	186	51
Eliquis	Apixaban	180	35
Hydrochlorothiazide	Hydrochlorothiazide	178	50
Escitalopram Oxalate	Escitalopram Oxalate	165	39
Metoprolol Succinate	Metoprolol Succinate	160	44
Allopurinol	Allopurinol	147	33
Furosemide	Furosemide	134	37
Tamsulosin Hcl	Tamsulosin Hcl	131	31
Gabapentin	Gabapentin	127	32
Alendronate Sodium	Alendronate Sodium	126	26
Sertraline Hcl	Sertraline Hcl	126	31
Duloxetine Hcl	Duloxetine Hcl	122	28
Fluticasone Propionate	Fluticasone Propionate	116	39
Simvastatin	Simvastatin	116	33
Metformin Hcl	Metformin Hcl	105	30
Spironolactone	Spironolactone	96	26
Metoprolol Tartrate	Metoprolol Tartrate	87	19
Triamcinolone Acetonide	Triamcinolone Acetonide	87	40
Estradiol	Estradiol	77	27
Amitriptyline Hcl	Amitriptyline Hcl	70	17
Venlafaxine Hcl Er	Venlafaxine Hcl	68	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	63	12
Tramadol Hcl	Tramadol Hcl	63	18
Potassium Chloride	Potassium Chloride	60	18
Citalopram Hbr	Citalopram Hydrobromide	58	13
Atenolol	Atenolol	57	13
Mounjaro	Tirzepatide	55	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	11
Metformin Hcl Er	Metformin Hcl	51	12
Ozempic	Semaglutide	50	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	49	32
Propranolol Hcl	Propranolol Hcl	49	12
Enalapril Maleate	Enalapril Maleate	47	12
Prednisone	Prednisone	47	25
Alprazolam	Alprazolam	43	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	13
Warfarin Sodium	Warfarin Sodium	43	13
Acyclovir	Acyclovir	42	14
Fluoxetine Hcl	Fluoxetine Hcl	42	14
Clopidogrel	Clopidogrel Bisulfate	40	12
Famotidine	Famotidine	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Glipizide Er	Glipizide	38	12
Montelukast Sodium	Montelukast Sodium	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	11
Mirtazapine	Mirtazapine	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	11
Rosuvastatin Calcium	Rosuvastatin Calcium	35	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Pregabalin	Pregabalin	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	11
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Lorazepam	Lorazepam	27	16
Lovastatin	Lovastatin	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	11
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Diazepam	Diazepam	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Finasteride	Finasteride	21	suppressed
Ramipril	Ramipril	21	suppressed
Temazepam	Temazepam	21	suppressed
Cephalexin	Cephalexin	19	18
Ibuprofen	Ibuprofen	19	suppressed
Linzess	Linaclotide	19	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Digoxin	Digoxin	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Azithromycin	Azithromycin	15	13
Doxepin Hcl	Doxepin Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Nystatin	Nystatin	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Topiramate	Topiramate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Budesonide Dr	Budesonide	12	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Glipizide	Glipizide	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error